Lau Bryan, Wentz Eryka, Ni Zhanmo, Yenokyan Karine, Vergara Candelaria, Mehta Shruti H, Duggal Priya
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Md.
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Md.
Am J Med. 2025 Feb;138(2):287-297.e21. doi: 10.1016/j.amjmed.2023.08.009. Epub 2023 Sep 9.
Persistent symptoms after severe acute respiratory disease coronavirus 2 (SARS-COV-2; long COVID) occur in 10%-55% of individuals, but the impact on daily functioning and disability remains unquantified.
To characterize disability associated with long COVID, we analyzed baseline data from an online, US-based cohort study. Adult participants included those reporting a history of COVID-19 (n = 8874) or never having COVID-19 (n = 633) without prior disability. The main outcomes were self-reported physical mobility, instrumental activities of daily living (IADL), and mental fatigue disability, assessed by measuring 5 disability components: difficulty walking a quarter mile or climbing 10 stairs (mobility), difficulty doing light or heavy housework (IADL), and Wood Mental Fatigue Inventory score (mental fatigue).
Of 7926 participants with long COVID, 65% were classified with at least one disability, as compared with 6% and 14% for resolved COVID and no COVID, respectively. Additionally, 22% were classified as disabled in all 3 categories. Age, prior comorbidity, increased body mass index, female sex, COVID-19 hospitalization, non-white/multi-race were associated with higher disability burden. Dizziness and heavy limbs at infection were associated with disability regardless of hospitalization. Dyspnea and tremors were associated with disability in non-hospitalized individuals. Vaccination was protective against disability.
We observed a high burden of new disability associated with long COVID, which has serious implications for individual and societal health. Longitudinal evaluation of COVID-19 patients is necessary to identify patterns of recovery and treatment options.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2;长期新冠)感染后持续症状在10%-55%的个体中出现,但对日常功能和残疾的影响仍未得到量化。
为了描述与长期新冠相关的残疾情况,我们分析了一项基于美国的在线队列研究的基线数据。成年参与者包括报告有新冠病毒病病史的人(n = 8874)或从未感染过新冠病毒且无既往残疾的人(n = 633)。主要结局是自我报告的身体活动能力、日常生活工具性活动(IADL)和精神疲劳残疾,通过测量5个残疾组成部分进行评估:行走四分之一英里或爬10级楼梯困难(活动能力)、进行轻度或重度家务困难(IADL)以及伍德精神疲劳量表得分(精神疲劳)。
在7926名患有长期新冠的参与者中,65%被归类为至少有一种残疾,而新冠已康复者和未感染新冠者的这一比例分别为6%和14%。此外,22%在所有三个类别中都被归类为残疾。年龄、既往合并症、体重指数增加、女性、新冠病毒病住院治疗、非白人/多种族与更高的残疾负担相关。感染时头晕和肢体沉重与残疾相关,无论是否住院。呼吸困难和震颤与未住院个体的残疾相关。接种疫苗可预防残疾。
我们观察到与长期新冠相关的新残疾负担很高,这对个人和社会健康具有严重影响。对新冠病毒病患者进行纵向评估对于确定康复模式和治疗选择很有必要。